This document discusses drug absorption through the gastrointestinal tract. It begins with an introduction and overview of the major routes of drug administration. It then describes the structure of cell membranes and the various mechanisms of drug transport across membranes, including both passive and active processes. Specific mechanisms discussed include diffusion, pore transport, ion-pair transport, and facilitated transport. The document focuses on drug absorption through the GI tract, outlining the three steps of transcellular transport and describing various passive transport processes. Finally, it discusses factors that can influence drug absorption through the GI, including physicochemical properties of the drug and various patient-related factors.
Gastrointestinal tract, Mechanism of drug absorption, Factors
affecting drug absorption, pH–partition theory of drug absorption. Formulation and physicochemical factors: Dissolution rate, Dissolution process, Noyes–Whitney equation and drug dissolution, Factors affecting the dissolution rate. Gastrointestinal absorption: Role of the dosage form: Solution (elixir, syrup and solution) as a dosage form ,Suspension as a dosage form, Capsule as a dosage form, Tablet as a dosage form ,Dissolution methods ,Formulation and processing factors, Correlation of in vivo data with in vitro dissolution data. Transport model: Permeability-Solubility-Charge State and the pH Partition Hypothesis, Properties of the Gastrointestinal Tract (GIT), pH Microclimate Intracellular pH Environment, Tight Junction Complex.
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products.
Drug Absorption ,m.pharm, semester 2, 1st yearManshiRana2
Drug absorption is the process of movement of unchanged drug from the site of administration to systemic circulation.
Absorption is the process of movement of unchanged drug from the site of administration to the site of measurement i.e. Plasma.
Gastrointestinal tract, Mechanism of drug absorption, Factors
affecting drug absorption, pH–partition theory of drug absorption. Formulation and physicochemical factors: Dissolution rate, Dissolution process, Noyes–Whitney equation and drug dissolution, Factors affecting the dissolution rate. Gastrointestinal absorption: Role of the dosage form: Solution (elixir, syrup and solution) as a dosage form ,Suspension as a dosage form, Capsule as a dosage form, Tablet as a dosage form ,Dissolution methods ,Formulation and processing factors, Correlation of in vivo data with in vitro dissolution data. Transport model: Permeability-Solubility-Charge State and the pH Partition Hypothesis, Properties of the Gastrointestinal Tract (GIT), pH Microclimate Intracellular pH Environment, Tight Junction Complex.
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products.
Drug Absorption ,m.pharm, semester 2, 1st yearManshiRana2
Drug absorption is the process of movement of unchanged drug from the site of administration to systemic circulation.
Absorption is the process of movement of unchanged drug from the site of administration to the site of measurement i.e. Plasma.
Drug absorption from git , Drug absorption from git , DIGESTION AND ABSORPTION , Transcellular / intracellular , transport , .Passive Transport Processes , Passive diffusion , Pore transport , Ion- pair transport , Facilitated or mediated diffusion
, Active transport processes , Primary , Secondary , Symport (Co-transport) , Antiport (Counter transport) , Paracellular / Intercellular Transport , Permeation through tight junctions of epithelial cells , Persorption , Vesicular or Corpuscular Transport (Endocytosis) , Pinocytosis , Phagocytosis , FACTORS INFLUENCING ABSORPTION OF DRUGS , DRUG DISSOLUTION , Factors affecting dissolution rate , DISSOLUTION APPARATUS , IVIVC (In vitro- in vivo correlation) , ROLE OF DOSAGE FORM , Transport model , pH Microclimate , Intracellular pH environment , Tight junction complex
mechanism of absorption /transport, factor affecting absorption.pptxkishan singh tomar
Gastro-interstinal track is most common site of absorbance. in this presentation we will study about different mechanism of absorbance and factor affecting in detail with important information drugs in markets and what could be done.
Drug absorption from git , Drug absorption from git , DIGESTION AND ABSORPTION , Transcellular / intracellular , transport , .Passive Transport Processes , Passive diffusion , Pore transport , Ion- pair transport , Facilitated or mediated diffusion
, Active transport processes , Primary , Secondary , Symport (Co-transport) , Antiport (Counter transport) , Paracellular / Intercellular Transport , Permeation through tight junctions of epithelial cells , Persorption , Vesicular or Corpuscular Transport (Endocytosis) , Pinocytosis , Phagocytosis , FACTORS INFLUENCING ABSORPTION OF DRUGS , DRUG DISSOLUTION , Factors affecting dissolution rate , DISSOLUTION APPARATUS , IVIVC (In vitro- in vivo correlation) , ROLE OF DOSAGE FORM , Transport model , pH Microclimate , Intracellular pH environment , Tight junction complex
mechanism of absorption /transport, factor affecting absorption.pptxkishan singh tomar
Gastro-interstinal track is most common site of absorbance. in this presentation we will study about different mechanism of absorbance and factor affecting in detail with important information drugs in markets and what could be done.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
1. Presented By
Wazed Ali
B.Pharm 3rd Year 6th semester
Roll-20801920061
Subject-
BIOPHARMACEUTICS AND
PHARMACOKINETICS-PT616
2. ▪ INTRODUCTION
▪ ROUTES OF DRUG ABSORPTION
▪ CELL MEMBRANE STRUCTURE AND PHYSIOLOGY
▪ MECHANISMS OF DRUG ABSORPTION THROUGH GIT
▪ FACTORS INFLUENCING DRUG ABSORPTION THROUGH GIT
▪ REFFERENCES
3. ▪ Drug absorption is defined as the process of movement of unchanged drug from
the site of administration to systemic circulation.
4. ▪ Drugs administered by three major routes:
1. The Enteral Route : includes peroral i.e. Gastrointestinal, sub- lingual/buccal and
rectal routes. The GI route is the most common for administration of majority of
drugs.
2. The Parenteral Route;includes all routes of administration through or under one
or more layers of skin.While no absorption is required when the drug is
administered i.v., it is necessary for extravas- cular parenteral routes like the
subcutaneous and the intramuscular routes.
3. The Topical Route:includes skin, eyes or other specific mem- branes. The
intranasal, inhalation, intravaginal and transdermal routes may be considered
enteral or topical according to different definitions.
5. ▪ For a drug to be absorbed and distributed into organs and tissues and eliminated
from the body, it must pass through one or more biological membranes/barriers at
various locations. Such a movement of drug across the membrane is called as drug
transport.
6. There three broad categories are:
1. Transcellular/intracellular transport
A.PassiveTransport Processes
I. Passive diffusion
II. Pore transport
III. Ion- pair transport
IV. Facilitated or mediated diffusion
B.Active transport processes
I.Primary
II. Secondary
a. Symport (Co-transport)
b.Antiport (Counter transport)
2. Paracellular/Intercellular Transport
A. Permeation through tight junctions of
epithelial cells
B. Persorption
3. Vesicular or CorpuscularTransport
(Endocytosis)
A. Pinocytosis
B. Phagocytosis
7. ▪ It is defined as the passage of drugs across the GI epithelium.
▪ 3 steps involved in transcellular transport of drug-
1.Permeation of Gl epithelial cell membrane
2.Movement across the intracellular space (cytosol).
3.Permeation of the lateral or basolateral membrane.
8. ▪ PassiveTransport Processes –
These transport processes do not require energy
other than that of molecular motion (Brownian motion) to pass through the lipid
bilayer. Passive transport processes can be further classified into following types –
I. Passive diffusion
II. Pore transport
III. Ion- pair transport
IV. Facilitated or mediated diffusion
9. ▪ Also called non-ionic diffusion, it is the major process for absorption of more than
90% of the drugs.
▪ The driving force for this process is the concentration gradient.
▪ Passive diffusion is best expressed by Fick’s first law of diffusion,
which states that the drug molecules diffuse from a region of
higher concentration to one of lower concentration until equilibrium is attained and
that the rate of diffusion is directly proportional to the concentration gradient across
the membrane.
Adolf Fick (1829–1901)
10. ▪ The drug moves down the concentration gradient indicating downhill transport.
▪ The process is energy-independent and non-saturable.
▪ The rate of drug transfer is directly proportional to the concen- tration gradient
between GI fluids and the blood compartment.
▪ Greater the area and lesser the thickness of the membrane, faster the diffusion;
thus, more rapid is the rate of drug absorption from the intestine than from the
stomach.
▪ The process is rapid over short distances and slower over long distances.
▪ Equilibrium is attained when the concentration on either side of the membrane
becomes equal.
11. ▪ Also known as convective transport, bulk flow or filtration. Important in the
absorption of low mol.Wt. (less than 100).Low molecular size (smaller than the
diameter of the pore) & generally water-soluble drugs through narrow, aqueous
filled channels or pores in the membrane structure.E.g. Urea, water & sugars.
▪ The driving force for the passage of the drugs is the hydrostatic or the osmotic
pressure difference across the membrane.
12. ▪ Absorption of drugs like quaternary ammonium compounds (+) and sulphonic acids (-),
which ionise (convert into molecules) under all pH conditions is known as ion-pair
transport.
▪ Such neutral complexes have both the required lipophilicity as well as aqueous
solubility for passive diffusion. Such a phenomenon is called as ion-pair transport.
13. ▪ • It is a carrier-mediated transport system that operates down the concentration
gradient (downhill transport) but at a much a faster rate than can be accounted by
simple passive diffusion.
▪ The driving force is concentration gradient (hence a passive process). Since no
energy expenditure is involved, the process is not inhibited by metabolic poisons
that interfere with energy production.
14. ▪ This transport process requires energy from ATP (Adenosine triphosphate) to move
drug molecules from extracellular to intracellular.
▪ These are two types-
I. Primary
II. Secondary
a. Symport (Co-transport)
b. Antiport (Counter transport)
15. ▪ Primaryactive transport -In this process, there is direct ATP requirement.
Moreover, the process transfers only one ion or molecule and in only one direction,
and hence called as uniporter e.g. Absorption of glucose.
▪ Secondary active transport – In these processes, there is no direct requirement of
ATP ie. It takes advantage of previously existing concentration gradient.
It’s has two types-
a. Symport (Co-transport)
b. Antiport (Counter transport)
16. A. Physicochemical factors:
1. Drug solubility& dissolution rate
2. Particle size& effective surface area
3. Polymorphism& amorphism
4. Pseudoploymorphism(hydrates/solvates)
5. Salt form of the drug.
B. Pharmaceuticalfactors:
Disintegration time (tablets/capsules)
▪ Dissolutiontime
▪ Manufacturing variables
▪ Pharmaceutical ingredients (excipients/adjuvants)
▪ Nature & type of dosage form
▪ Product age & storage condition
C. Patient related factors:
1) Route of administration
2) Membrane physiology
a) Nature of cell membrane
b) Transport processes
3) Age
4) Gastric emptying time
5) Intestinal transit time
17. ▪ Bio pharmaceutics and Pharmacokinetics-A Treatise, By D. M. Brahmankar and
Sunil B.Jaiswal,Vallabh Prakashan Pitampura, Delhi .ISBN81-85731-03-9